FDA Encourages Industry Leaders to Streamline, Enhance Product Recall Communications to Safeguard Foods for Infants and Children

The U.S. Food and Drug Administration today called for increased attention to product recall communications

Readmore
FDA Eliminates Risk Evaluation and Mitigation Strategies (REMS) for Autologous Chimeric Antigen Receptor CAR T cell Immunotherapies

The U.S. Food and Drug Administration announced today that it has eliminated the Risk Evaluation

Readmore